Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 38-5 - September 5, 2024
- Latest edition
- Editor: David E. Fisher
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 4 6 5 2 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 4 6 5 4 - 8
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide infor… Read more
Purchase options
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.
- Contains 16 relevant, practice-oriented topics including high risk non-melanoma skin cancers; progress in immune checkpoints for melanoma therapy; targeted therapy innovations for melanoma; advances in vaccines for melanoma; microbiome and immunotherapy; Merkel cell carcinoma; and more.
- Provides in-depth clinical reviews on cutaneous oncology, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Oncology, hematology
Epidemiology and Screening for Melanoma
Cutaneous Imaging Techniques
Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
Nevi and Melanoma
Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
Targeted Therapy Innovations for Melanoma
Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
Melanoma Brain Metastasis: Biology and Therapeutic Advances
Advances in Vaccines for Melanoma
Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
Cutaneous T-cell Lymphoma
Cutaneous B-Cell Lymphomas
Merkel Cell Carcinoma
Cutaneous Imaging Techniques
Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
Nevi and Melanoma
Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
Targeted Therapy Innovations for Melanoma
Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
Melanoma Brain Metastasis: Biology and Therapeutic Advances
Advances in Vaccines for Melanoma
Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
Cutaneous T-cell Lymphoma
Cutaneous B-Cell Lymphomas
Merkel Cell Carcinoma
- Edition: 1
- Latest edition
- Volume: 38-5
- Published: September 5, 2024
- Language: English
DF
David E. Fisher
Affiliations and expertise
Edward Wigglesworth Professor & Chairman
Dept of Dermatology
Director, Melanoma Program MGH Cancer Center
Director, Cutaneous Biology Research Center
Massachusetts General Hospital
Harvard Medical School